Clinical Trial Update: Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab [NA]

View source ↗

Summary

Clinical Trial Update describes an ongoing study evaluating biomarkers in diabetic retinopathy and diabetic macular edema, comparing faricimab to a biosimilar r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Faricimab (faricimab)
• Ranibizumab (biosimilar) (Ranibizumab)

Snippet

Sponsor: Osijek University Hospital | Conditions: Diabetic Retinopathy (DR), Diabetic Macular Edema (DME) | NA | Status: RECRUITING